MindImmune raises $10.2M in Series A extension, totaling $30M, to advance Alzheimer's therapy as Isaac Stoner takes the CEO role.
Amount Raised
$10.2 Million
Round Type
Series A
KingstonBiotechnologyHealthcareHealth CareTherapeuticsInvestors
Description
MindImmune Therapeutics has successfully closed a $10.2 million Series A extension, bringing its total Series A funding to $30 million. The company is focused on developing therapies targeting inflammation in neurodegenerative diseases like Alzheimer’s. Alongside this funding milestone, Isaac Stoner has been appointed as CEO. Reetika Bhardwaj of Dolby Family Ventures will also join the Board of Directors.
Quick answer
MindImmune Therapeutics raised $10.2 Million in a Series A round, dated November 24, 2025. Investors: Dolby Family Ventures. MindImmune Therapeutics is based in Kingston, Rhode Island, United States.
- How much did MindImmune Therapeutics raise?
- MindImmune Therapeutics raised $10.2 Million in a Series A round on November 24, 2025.
- Who invested in MindImmune Therapeutics?
- Dolby Family Ventures is named as investors in this round.
- What does MindImmune Therapeutics do?
- MindImmune Therapeutics is a venture-backed biotechnology company developing products that target the immunological drivers of neurodegenerative disease.
- Where is MindImmune Therapeutics based and how big is it?
- MindImmune Therapeutics is based in Kingston, Rhode Island, United States.
- Who are the decision-makers at MindImmune Therapeutics?
- Fundz holds 2 contacts at MindImmune Therapeutics, including the Founder and CSO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as MindImmune Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Parabilis Medicines raised $305M (Series F) on January 8, 2026.
- Jade Biosciences raised $45M (Post-IPO Equity) on December 15, 2025.
- Oncotelic Therapeutics raised $275K on December 4, 2025.
- Azora Therapeutics, Inc. (DE) raised $4.3M on November 28, 2025.
- Verrica raised $50M on November 25, 2025.
- ClearPoint Neuro raised $18M on November 20, 2025.
Who to call at MindImmune Therapeutics, and when
A new round usually means MindImmune Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MindImmune Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MindImmune Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MindImmune Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MindImmune Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMindImmune Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.